Durgical
EN
Open the app

Fever with low neutrophils: the first hour

  • Haematological emergency

After chemotherapy a fever can be the only sign of an infection that kills within hours. Antibiotics in the first hour save lives.

Updated

What it is

Febrile neutropenia is fever (a single temperature of about 38.3 °C, or 38.0 °C sustained for an hour) in a patient whose absolute neutrophil count is below 0.5 × 10⁹/L, or is expected to fall below it within the next two days. It is most common 7–14 days after chemotherapy. Bacteria from the patient's own gut, skin and mouth, entering through mucositis or a central line, cause most infections; fungi become important when neutropenia lasts longer than about a week.

How to recognise it

  • Assume febrile neutropenia in any patient with fever within weeks of chemotherapy, even before the count is back.
  • Look for shock: low blood pressure, fast heart rate, cold peripheries, confusion, falling urine output.
  • Examine the mouth, skin, central line exit site, perianal area and lungs; avoid rectal examination and rectal temperatures.
  • Steroids and paracetamol can blunt or hide the fever; a neutropenic patient who looks unwell without fever is treated the same way.
  • Risk is assessed by principle: short expected neutropenia, solid tumour, outpatient onset, no comorbidity and stable signs mean lower risk; scores such as MASCC formalise this.
  • In dengue- and malaria-endemic areas of Colombia, fever after chemotherapy is still febrile neutropenia first; other causes are tested in parallel, not instead.

What to do at once (and why)

  1. Recognise it at triage: fever or feeling unwell within weeks of chemotherapy is triaged as urgent, like suspected sepsis.
  2. Assess airway, breathing and circulation; resuscitate shock with intravenous fluids and escalate early.
  3. Take blood cultures (peripheral and from every central line lumen) and other targeted samples, but do not let them delay antibiotics.
  4. Give an empirical broad-spectrum intravenous antipseudomonal beta-lactam within the first hour, because gram-negative sepsis can kill within hours.
  5. Add anti-gram-positive cover (for example vancomycin) only for specific reasons: shock, line or skin infection, pneumonia, or known resistant organisms.
  6. Assess risk: stable, low-risk patients may complete treatment with oral antibiotics, sometimes as outpatients, under a clear protocol.
  7. Re-examine daily; fever persisting beyond about four to seven days on antibiotics prompts a search for fungal infection (chest CT, fungal markers).

Who is at lower and higher risk?

FeatureLower riskHigher risk
Expected neutropeniaShort, under about seven daysLong, over seven days (leukaemia induction, transplant)
Underlying cancerSolid tumourAcute leukaemia, transplant
CirculationNormal blood pressureLow blood pressure or shock
Other problemsNoneLung disease, kidney or liver failure, dehydration, confusion
SettingFever began at home, patient walking and wellAlready in hospital, unwell, severe mucositis
Usual managementPossible oral antibiotics, early dischargeIntravenous antibiotics in hospital

Costly mistakes

  • The commonest costly mistake is time: waiting in the emergency department for the count, the cultures or a doctor before the first antibiotic dose.
  • A central line with redness or pus at the exit site, or rigors when it is flushed, suggests line infection and may require removing the line.
  • Diarrhoea after antibiotics in a neutropenic patient needs a Clostridioides difficile test; abdominal pain with neutropenia raises the possibility of neutropenic enterocolitis (typhlitis).
  • Granulocyte colony-stimulating factor is mainly used to prevent neutropenia after chemotherapy; it is not routine treatment once febrile neutropenia has started.

Tests and next step

  • Full count with differential, creatinine, electrolytes, liver tests, lactate, and blood cultures from a peripheral vein and each line lumen.
  • Urine culture, chest radiograph if respiratory signs, and swabs or samples from any visible source.
  • Persistent fever on antibiotics: chest CT and fungal markers such as galactomannan, guided by the infectious diseases or haematology team.
  • Shock, organ failure or a fall in consciousness: intensive care review.

Common traps

  • Waiting for the neutrophil count in a febrile patient after chemotherapy: antibiotics are given without waiting for it.
  • Being reassured by the absence of pus, infiltrate or meningism: neutrophils make those signs.
  • Taking a rectal temperature or doing a rectal examination: it can push gut bacteria into the blood.
  • Relying on fever to spot the sick patient: a patient on steroids or antipyretics may have no fever but be in shock.
  • Calling a fever after chemotherapy 'probably dengue' in an endemic area: that label must not delay antibiotics.

Test yourself

Think of the answer, then tap the question to see it.

Why can a patient with severe neutropenia have a life-threatening infection with only a fever?

Neutrophils produce pus, redness and lung infiltrates; without them those signs are faint or absent, so fever may be the only clue.

A patient 10 days after chemotherapy arrives with fever; the count will take an hour. What should happen first?

Assess for shock, take cultures quickly and give an empirical intravenous antipseudomonal beta-lactam within the first hour, without waiting for the count.

Which features suggest a patient with febrile neutropenia is at lower risk and might be treated orally?

Short expected neutropenia, a solid tumour, onset at home, normal blood pressure and no serious comorbidity or organ dysfunction.

Why is a rectal temperature avoided in a neutropenic patient?

It can damage the mucosa and push gut bacteria into the bloodstream in a patient who cannot contain them.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Febrile Neutropenia (StatPearls (NCBI Bookshelf), 2023); Infection and Neutropenia during Cancer Treatment (National Cancer Institute (NCI), 2026); Information for Patients Who Are Getting Chemotherapy (Preventing Infections in Cancer Patients) (Centers for Disease Control and Prevention, 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.